The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Aminobisphosphonates Cause Osteoblast Apoptosis and Inhibit Bone Nodule Formation In Vitro
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sato, M., Grasser, W., Endo, N., Akins, R., Simmons, H., Thompson, D. D., Golub, E., & Rodan, G. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115539 · Cited by 1,004 · cited 2×
“The mechanisms by which bisphosphonates might be taken up by osteoblasts are less clear, but bisphosphonates can be taken up by any cell by fluid phase endocytosis; also, studies using radiolabeled bisphosphonates have shown that a proportion of the administered dose is located at bone-forming surfaces [29].”
Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin
Plotkin, L. I., Weinstein, R. S., Parfitt, A. M., Roberson, P. K., Manolagas, S. C., & Bellido, T. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6800 · Cited by 890 · cited 2×
“For example, it has been reported that bisphosphonates at very low concentrations can protect against apoptosis induced by etoposide and corticosteroids in osteoblasts and osteocytes through connexin 43 channels and extracellular signal–regulated kinase (ERK) phosphorylation [8, 9].”
Nancollas, G. H., Tang, R., Phipps, R. J., Henneman, Z., Gulde, S., Wu, W., Mangood, A., Russell, R. G. G., & Ebetino, F. H. (2006) · Bone · doi:10.1016/j.bone.2005.05.003 · Cited by 862 · cited 1×
“Although all bisphosphonates share the same phosphorus–carbon– phosphorus core, different bisphosphonates differ markedly in their affinity for hydroxyapatite binding, and this is thought to play a role in determining their duration of action [7].”
Cited by
The Pathogenesis of Bisphosphonate-Related Osteonecrosis of the Jaw: So Many Hypotheses, So Few Data
Allen, M. R., & Burr, D. B. (2009) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2009.01.007 · Cited by 451
Silk fibroin/hydroxyapatite composites for bone tissue engineering
Farokhi, M., Mottaghitalab, F., Samani, S., Shokrgozar, M. A., Kundu, S. C., Reis, R. L., Fatahi, Y., & Kaplan, D. L. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.10.001 · Cited by 437
Novel actions of bisphosphonates in bone: Preservation of osteoblast and osteocyte viability
Bellido, T., & Plotkin, L. I. (2011) · Bone · doi:10.1016/j.bone.2010.08.008 · Cited by 265
Effects of Teriparatide, Alendronate, or Both in Women with Postmenopausal Osteoporosis
Finkelstein, J. S., Wyland, J. J., Lee, H., & Neer, R. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1703 · Cited by 265
Pyrophosphate: a key inhibitor of mineralisation
Orriss, I. R., Arnett, T. R., & Russell, R. G. G. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.03.003 · Cited by 181
“There are more recent studies suggesting that BPs may inhibit bone formation and mineralisation, an effect which may, because of the structural similarities with pyrophosphate, involve direct physicochemical effects on hydroxyapatite crystal propagation [112,113].”
Background
Metadata
- Authors
- Idris, A. I., Rojas, J., Greig, I. R., van’t Hof, R. J., & Ralston, S. H.
- Venue
- Calcified Tissue International
- Published
- 2008-02-08
- Volume
- 82
- Issue
- 3
- Pages
- 191-201
- ISSN
- 0171-967X (ISSN-L)
- 1432-0827
- OpenAlex
- W2110466791
- Cited by
- 203
- References
- 3
- FWCI
- 9.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.